Skip to content Skip to navigation

Invasive pneumococcal disease in Fiji: clinical syndromes, epidemiology, and the potential impact of pneumococcal conjugate vaccine

TitleInvasive pneumococcal disease in Fiji: clinical syndromes, epidemiology, and the potential impact of pneumococcal conjugate vaccine
Publication TypeJournal Article
Year of Publication2010
AuthorsRussell, FM, Carapetis, JR, Tikoduadua, L, Paeds, D, Chandra, R, Seduadua, A, Satzke, C, Pryor, J, Buadromo, E, Waqatakirewa, L, Mulholland, EK
JournalPediatr Infect Dis JPediatr Infect Dis J
Volume29
Pagination870-2
Date PublishedSep
ISBN Number1532-0987 (Electronic)<br/>0891-3668 (Linking)
Accession Number20622710
KeywordsAdolescent, Adult, Age Factors, Aged, Aged, 80 and Over, Child, Child, Preschool, Female, Fiji/epidemiology, Humans, Incidence, Infant, Infant, Newborn, Male, Middle Aged, Mortality, Pneumococcal Infections/ epidemiology/mortality/ pathology/prevention & control, Pneumococcal Vaccines/ immunology, Vaccination/utilization, Vaccines, Conjugate/immunology, Young Adult
AbstractInvasive pneumococcal disease (IPD) epidemiology and the potential impact of the pneumococcal conjugate vaccine in Fiji are documented. The annual incidence was 26.5 and 10.9 in those aged or =55 years per 100,000, respectively. The case fatality rate was 9.4% and 67% in 65 year olds, respectively. One pneumococcal death and case would be prevented in